Home › Ovarian Epithelial Carcinoma

Ovarian Epithelial Carcinoma clinical trials recruiting in the U.S.

26 studies for Ovarian Epithelial Carcinoma are recruiting participants at sites across the United States.

Cities with the most studies

• Boston, MA9 studies
• Durham, NC8 studies
• New York City, NY7 studies
• San Diego, CA7 studies
• Chicago, IL7 studies
• Philadelphia, PA6 studies
• Houston, TX6 studies
• Cleveland, OH5 studies
• Portland, OR5 studies
• Edison, NJ5 studies
• Salt Lake City, UT5 studies
• Los Angeles, CA5 studies
• Baltimore, MD5 studies
• Minneapolis, MN5 studies
• Dallas, TX4 studies
• Arlington, VA4 studies
• New Haven, CT4 studies
• Queens, NY4 studies
• San Antonio, TX4 studies
• Birmingham, AL4 studies
• St. Louis, MO4 studies
• Seattle, WA4 studies
• Oklahoma City, OK3 studies
• Mountain View, CA3 studies
• Nashville, TN3 studies
• Grand Rapids, MI3 studies
• Clifton, NJ3 studies
• Rochester, MN3 studies
• Shreveport, LA3 studies
• New Orleans, LA3 studies
• Aurora, CO3 studies
• Columbus, OH3 studies
• San Francisco, CA3 studies
• Providence, RI3 studies
• Washington, DC3 studies
• Dayton, OH3 studies
• Indianapolis, IN3 studies
• West Palm Beach, FL3 studies
• Sioux Falls, SD3 studies

By state

• Alabama4 studies
• Arizona4 studies
• California10 studies
• Colorado4 studies
• Connecticut4 studies
• Florida10 studies
• Georgia3 studies
• Illinois8 studies
• Indiana3 studies
• Louisiana4 studies
• Maryland6 studies
• Massachusetts10 studies
• Michigan5 studies
• Minnesota7 studies
• Missouri5 studies
• New Jersey9 studies
• New York10 studies
• North Carolina9 studies
• Ohio9 studies
• Oklahoma3 studies
• Oregon6 studies
• Pennsylvania10 studies
• Rhode Island3 studies
• South Dakota3 studies
• Tennessee6 studies
• Texas12 studies
• Utah5 studies
• Virginia6 studies
• Washington6 studies

Recently updated studies

From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.